← Evidence map

ReviewJournal of internal medicine2021

Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis.

F PiehlPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

67 papers cite itlatest 60 shown

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33258193